CIK: 0001325083 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value ($000): $131,596 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Biohaven Pharmactl Hldg Co L | 749,815 | $38,593 | 29.3% | $25.00 | — | COM | G11196105 |
| — | Corbus Pharmaceuticals HLDGS | 4,985,870 | $34,652 | 26.3% | $4.98 | — | COM | 21833P103 |
| — | Abeona Therapeutics Inc | 2,359,767 | $17,368 | 13.2% | $4.97 | — | COM | 00289Y107 |
| KRYS | Krystal Biotech Inc | 209,986 | $6,909 | 5.3% | $10.08 | +133.8% | COM | 501147102 |
| — | Blackstone Group LP | 153,000 | $5,350 | 4.1% | $34.97 | — | COM UNIT LTD | 09253U108 |
| MO | Altria Group Inc | 90,000 | $5,169 | 3.9% | $29.72 | 0.0% | COM | 02209S103 |
| — | DowDupont Inc | 90,000 | $4,798 | 3.6% | $53.31 | — | COM | 26078J100 |
| ALDX | Aldeyra Therapeutics Inc | 484,096 | $4,371 | 3.3% | $8.65 | -1.8% | COM | 01438T106 |
| KBA | Kraneshares TR | 96,000 | $3,061 | 2.3% | $31.89 | — | BOSERA MSCI CH | 500767405 |
| — | Electrocore Inc | 396,825 | $2,778 | 2.1% | $16.51 | — | COM | 28531P103 |
| AVXL | Anavex Life Sciences Corp | 724,205 | $2,209 | 1.7% | $3.56 | -33.0% | COM NEW | 032797300 |
| ENTX | Entera Bio Ltd | 475,540 | $2,057 | 1.6% | $6.29 | -35.5% | SHS | M40527109 |
| — | Galmed Pharmaceuticals Ltd | 206,099 | $1,684 | 1.3% | $11.90 | — | SHS | M47238106 |
| — | Eiger Biopharmaceuticals Inc | 75,238 | $1,052 | 0.8% | $9.85 | — | COM | 28249U105 |
| — | Soligenix Inc. | 837,800 | $767 | 0.6% | $2.11 | — | COM | 834223307 |
| — | Molecular Templates | 113,905 | $662 | 0.5% | $4.04 | — | COM | 608550109 |
| — | Lipocine Inc New | 50,000 | $116 | 0.1% | $1.30 | — | COM | 53630X104 |